The IL-1 receptor antagonist anakinra (kineret®) stabilizes the NLRP3 mutation-specific risk for hearing loss in patients with severe cryopyrin-associated periodic syndromes (CAPS)

Overview of attention for article published in Pediatric Rheumatology, September 2014

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 2 Dimensions

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 148 followers.

https://t.co/KcamxcEByZ

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.